Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Etanercept on Rheumatoid Cachexia
2006-006562-42Phase 4Terminated
- Sponsor
- University Hospitals of Derby and Burton
- Start
- Jan 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in rheumatoid arthritis (RA) and rheumatoid cachexia, sponsored by University Hospitals of Derby and Burton. Primary endpoint: Peripheral lean body mass change. Started Jan 2009; status: terminated.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)rheumatoid cachexia
Beyond the preview
Go deeper on 2006-006562-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006562-42.